By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


DelMar Pharmaceuticals 

999 West Broadway
Suite 720
  British Columbia  V5Z 1K5  Canada
Phone: 1-604-629-5989 Fax:



Company News
DelMar Pharmaceuticals Provides Update On Glioblastoma Clinical Trial And Results Of Warrant Tender Offer 8/19/2014 7:45:29 AM
DelMar Pharmaceuticals Announces Change Of Fiscal Year End And Provides Update On Glioblastoma Clinical Trial 7/25/2014 8:42:51 AM
DelMar Pharmaceuticals Receives Funding From The Canadian Federal Government 7/9/2014 9:37:08 AM
DelMar Pharmaceuticals To Webcast, Live, At June 5th 6/3/2014 6:33:06 AM
DelMar Pharmaceuticals To Present At The Third Annual Marcum LLP MicroCap Conference 5/22/2014 6:56:45 AM
DelMar Pharmaceuticals Gives Quarterly Shareholder Update 5/21/2014 6:18:51 AM
DelMar Pharmaceuticals Updates VAL-083 Glioblastoma Clinical Trial Progress 5/16/2014 9:10:24 AM
DelMar Pharmaceuticals To Present Interim Clinical Data For Ongoing VAL-083 Glioblastoma Multiforme Trial At American Society of Clinical Oncology 5/15/2014 7:06:33 AM
DelMar Pharmaceuticals VAL-083 Clinical Trial In GBM Demonstrates Continued And Promising Progress At American Association for Cancer Research 4/9/2014 9:27:29 AM
DelMar Pharmaceuticals Presents Promising Pre-Clinical Data With VAL-083 In Lung Cancer 4/7/2014 8:53:38 AM